Error: Could not add to watchlist. X

CFS Managed Investment Fund - Global Health & Biotechnology

+ Watchlist
COLFHLB:AU
2.2364
AUD
0.0542
2.37%
As of 00:59:30 ET on 06/29/2015.
Volume
0
Previous Close
2.29
52Wk Range
1.40 - 2.29
1 Yr Return
55.29%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 06/29/2015)
2.2364
Total Assets (m AUD) (on 02/27/2015)
26.299
Inception Date
04/28/2000
Last Dividend (on 12/15/2014)
-
Dividend Indicated Gross Yield
-
Fund Managers
DAVID L LEARY
Front Load Fee
4.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.05%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Medtronic PLC 17.16 k 1.70 m 6.46
Bristol-Myers Squibb Co 20.44 k 1.59 m 6.03
Allergan plc 3.90 k 1.46 m 5.54
Gilead Sciences Inc 10.14 k 1.34 m 5.11
McKesson Corp 3.41 k 999.37 k 3.80
UnitedHealth Group Inc 6.44 k 933.62 k 3.55
Regeneron Pharmaceuticals Inc 1.63 k 862.61 k 3.28
Aetna Inc 6.04 k 767.93 k 2.92
Alkermes PLC 8.04 k 723.22 k 2.75
HCA Holdings Inc 6.75 k 618.03 k 2.35
Profile
Colonial First State Mangaged Investment Funds - Global Health & Biotechnology Fund is a unit trust incorporated in Australia. The objective of the Fund is to provide long-term capital growth by predominantly investing in companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, medical devices, or medical services.
ADDRESS
Colonial First State Asset Mgt Ltd
11 Harbour Street
Sydney NSW 2000
Australia
PHONE
Tel: 61-2-9303-3000